These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26050127)

  • 1. Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease.
    Mundel P; Greka A
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):388-92. PubMed ID: 26050127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-Targeted Treatment for Proteinuric Kidney Disease.
    Mundel P
    Semin Nephrol; 2016 Nov; 36(6):459-462. PubMed ID: 27987545
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease.
    Herrera M; Söderberg M; Sabirsh A; Valastro B; Mölne J; Santamaria B; Valverde AM; Guionaud S; Heasman S; Bigley A; Jermutus L; Rondinone C; Coghlan M; Baker D; Quinn CM
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F748-F759. PubMed ID: 27440778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of B7-1 in proteinuria of glomerular origin.
    Novelli R; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2018 Sep; 14(9):589-596. PubMed ID: 29959373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.
    Delville M; Baye E; Durrbach A; Audard V; Kofman T; Braun L; Olagne J; Nguyen C; Deschênes G; Moulin B; Delahousse M; Kesler-Roussey G; Beaudreuil S; Martinez F; Rabant M; Grimbert P; Gallazzini M; Terzi F; Legendre C; Canaud G
    J Am Soc Nephrol; 2016 Aug; 27(8):2520-7. PubMed ID: 26701979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease.
    Bassi R; Fornoni A; Doria A; Fiorina P
    Diabetologia; 2016 Jan; 59(1):21-29. PubMed ID: 26409459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocentric view of glomerular proteinuria: Focused on cytoskeletal changes and toward promising targeted therapies and challenges.
    Kuo MC; Liang PI; Chang JM
    Kaohsiung J Med Sci; 2021 Jul; 37(7):539-546. PubMed ID: 33942997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?
    Salant DJ
    J Am Soc Nephrol; 2016 Apr; 27(4):963-5. PubMed ID: 26400567
    [No Abstract]   [Full Text] [Related]  

  • 9. Abatacept in B7-1-positive proteinuric kidney disease.
    Yu CC; Fornoni A; Weins A; Hakroush S; Maiguel D; Sageshima J; Chen L; Ciancio G; Faridi MH; Behr D; Campbell KN; Chang JM; Chen HC; Oh J; Faul C; Arnaout MA; Fiorina P; Gupta V; Greka A; Burke GW; Mundel P
    N Engl J Med; 2013 Dec; 369(25):2416-23. PubMed ID: 24206430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study.
    Rivard CJ; Tanabe T; Lanaspa MA; Watanabe H; Nomura S; Andres-Hernando A; Garth K; Sekijima M; Ishimoto T; Ariyoshi Y; Garcia GE; Shah J; Lennan B; Tasaki M; Pomposelli T; Shimizu A; Sachs DH; Johnson RJ; Yamada K
    Transpl Int; 2018 Oct; 31(10):1164-1177. PubMed ID: 29722117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The podocyte as a direct target of immunosuppressive agents.
    Schönenberger E; Ehrich JH; Haller H; Schiffer M
    Nephrol Dial Transplant; 2011 Jan; 26(1):18-24. PubMed ID: 20937691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome.
    Trachtman H; Gipson DS; Somers M; Spino C; Adler S; Holzman L; Kopp JB; Sedor J; Overfield S; Elegbe A; Maldonado M; Greka A
    Kidney Int Rep; 2018 Jan; 3(1):115-121. PubMed ID: 29340321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of nephrotic syndrome: immuno- or rather podocyte therapy?].
    Lewko B
    Postepy Hig Med Dosw (Online); 2016 May; 70():459-70. PubMed ID: 27180964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.
    Eto N; Wada T; Inagi R; Takano H; Shimizu A; Kato H; Kurihara H; Kawachi H; Shankland SJ; Fujita T; Nangaku M
    Kidney Int; 2007 Aug; 72(4):455-63. PubMed ID: 17457371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
    Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
    J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal change disease: a CD80 podocytopathy?
    Ishimoto T; Shimada M; Araya CE; Huskey J; Garin EH; Johnson RJ
    Semin Nephrol; 2011 Jul; 31(4):320-5. PubMed ID: 21839364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nephrotic syndrome in childhood].
    Reusz G; Szabó A; Fekete A
    Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuria: abate or applaud abatacept in proteinuric kidney disease?
    Reiser J; Alachkar N
    Nat Rev Nephrol; 2014 Mar; 10(3):128-30. PubMed ID: 24375054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.